BoniSleep
Natural health product licensed in Canada
- Licence holder
- Viva Pharmaceutical Inc.
- NPN or DIN-HM
- 80086702
- Status
- Active licence
- Licence date
- 28 June 2018
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Valeriana officinalis L.: L'absence de valépotriates doit être prouvée par des rapports d'analyse. L'étiquetage doit comporter un avertissement déconseillant l'emploi aux enfants de moins de 12 ans.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Pteria martensii Source : Perle | 30 mg | Not calculated |
| Vitamine B6 Source : Chlorhydrate de pyridoxine | 1.5 mg | 1,500 µg |
| Acide gamma-aminobutyrique Source : Acide 4-aminobutanoïque | 125 mg | Not calculated |
| Matricaria chamomilla Source : Fleur Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 75 mg | 18.75 mg | Not calculated |
| L-5-hydroxytryptophane Source : 5-HTP | 25 mg | Not calculated |
| Rhodiola rosea Source : Racine Extraction ratio : 7:1 Dry plant equivalent : 50.05 mg | 7.15 mg | Not calculated |
| L-arginine Source : L-arginine | 50 mg | Not calculated |
| Magnésium Source : Oxyde de magnésium | 50 mg | 50,000 µg |
| N-éthyl-L-glutamine Source : L-Théanine | 25 mg | Not calculated |
| N-acétyl-5-méthoxytryptamine Source : Mélatonine | 1.5 mg | Not calculated |
| Valeriana officinalis Source : Rhizome Extract : Matériel brut sec Extraction ratio : 5:1 Dry plant equivalent : 75 mg | 15 mg | Not calculated |
| Passiflora incarnata Source : Sommité Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 320 mg | 80 mg | Not calculated |
| Humulus lupulus Source : Strobiles Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 75 mg | 18.75 mg | Not calculated |
| Withania somnifera Source : Racine Extraction ratio : 15:1 Dry plant equivalent : 49.95 mg | 3.33 mg | Not calculated |
Non-medicinal ingredients
Silice pyrogénée, Cellulose microcristalline, Gélatine, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Capsule | 1 day |
Uses authorised in Canada
Text supplied in English because no French text is available.
Valerian is traditionally used in Herbal Medicine to help relieve nervousness (calmative/sedative) and as a) sleep aid / (to) help(s) to promote sleep.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner if sleeplessness persists continuously for more than 3 weeks (chronic insomnia). Consult a health care practitioner if symptoms persist or worsen. Consult a health care practitioner prior to use if you are taking carbidopa or drugs/supplements with serotonergic activity. These may include, but are not limited to, L-tryptophan, S-adenosylmethionine (SAMe), St. John's wort, antidepressants, pain killers, over the counter cough and cold medication containing dextromethorphan, anti-nausea medication and anti-migraine medication. Discontinue use and consult a health care practitioner if you show signs of weakness, oral ulcers, or abdominal pain accompanied by severe muscle pain or if you experience skin changes. Consumption with alcohol, other drugs or natural health products with sedative properties is not recommended. Consult a health care practitioner prior to use if you have depression and/or related diseases. If you experience any of the following symptoms within a few hours after taking this product, discontinue use and consult a health care practitioner: changes in mental state such as restlessness or confusion, increased heart rate, enlarged pupils, loss of muscle coordination, sweating, shivering and/or gastrointestinal symptoms such as nausea, vomiting, diarrhea. If you are taking one of the following medications, consult a health care practitioner prior to use: anticoagulant, anticonvulsant, blood pressure medications, immunosuppressive medications, sedative, hypnotic or psychotropic medications, or steroids. If you have one of the following conditions, consult a health care practitioner prior to use: asthma, cardiovascular disease, chronic kidney disease, depression, diabetes or hypoglycaemia, hormonal disorder, immune system disease, liver disease, migraine, or seizure disorders. Do not drive or use machinery for 5 hours after taking melatonin.
Source
Official Health Canada record, licence 80086702
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.